Vaspin in newly and previously diagnosed Chinese type 2 diabetic females: a case-control study

1. Manson JE, Willett WC, Stampfer MJ, Colditz GA, Hunter DJ, Hankinson SE, et al. Body weight and mortality among women. N Engl J Med. 1995; 333: 677-85.10.1056/NEJM1995091433311017637744Search in Google Scholar

2. Rosengren A, Wedel H, Wilhelmsen L. Body weight and weight gain during adult life in men in relation to coronary heart disease and mortality. A prospective population study. Eur Heart J. 1999; 20:269-77.10.1053/euhj.1998.1235Search in Google Scholar

3. Stears AJ, Byrne CD. Adipocyte metabolism and the metabolic syndrome. Diabetes Obes Metab. 2001; 3: 129-42.10.1046/j.1463-1326.2001.00151.x11412277Search in Google Scholar

4. Hida K, Wada J, Eguchi J, Zhang H, Baba M, Seida A, et al. Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci USA. 2005; 102:10610-5.10.1073/pnas.0504703102118079916030142Search in Google Scholar

5. Kempf K, Rose B, Illig T, Rathmann W, Strassburger K, Thorand B, et al. Vaspin (SERPINA12) genotypes and risk of type 2 diabetes: Results from the MONICA/ KORA studies. Exp Clin Endocrinol Diabetes. 2010; 118:184-9.10.1055/s-2008-108149918726871Search in Google Scholar

6. Kloting N, Berndt J, Kralisch S, Kovacs P, Fasshauer M, Schon MR, et al. Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes. Biochem Biophys Res Commun. 2006; 339: 430-6.10.1016/j.bbrc.2005.11.03916298335Search in Google Scholar

7. Youn BS, Kloting N, Kratzsch J, Lee N, Park JW, Song ES, et al. Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes. 2008; 57:372-7.10.2337/db07-104517991760Search in Google Scholar

8. Gulcelik NE, Karakaya J, Gedik A, Usman A, Gurlek A. Serum vaspin levels in type 2 diabetic women in relation to microvascular complications. Eur J Endocrinol. 2009; 160:65-70.10.1530/EJE-08-072318952766Search in Google Scholar

9. Ye Y, Hou XH, Pan XP, Lu JX, Jia WP. Serum vaspin level in relation to postprandial plasma glucose concentration in subjects with diabetes. Chin Med J (Engl). 2009; 122:2530-3.Search in Google Scholar

10. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2008; 31(Suppl 1):S55-60.10.2337/dc08-S05518165338Search in Google Scholar

11. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18:499-502.10.1093/clinchem/18.6.499Search in Google Scholar

12. Seeger J, Ziegelmeier M, Bachmann A, Lossner U, Kratzsch J, Bluher M, et al. Serum levels of the adipokine vaspin in relation to metabolic and renal parameters. J Clin Endocrinol Metab. 2008; 93:247-51.10.1210/jc.2007-185317956947Search in Google Scholar

13. Tan BK, Heutling D, Chen J, Farhatullah S, Adya R, Keay SD, et al. Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance. Diabetes. 2008; 57:1501-7.10.2337/db08-012718375437Search in Google Scholar

14. Lee MK, Jekal Y, Im JA, Kim E, Lee SH, Park JH, et al. Reduced serum vaspin concentrations in obese children following short-term intensive lifestyle modification. Clin Chim Acta. 2010; 411:381-5.10.1016/j.cca.2009.12.00320018186Search in Google Scholar